COMPARATIVE ASSESSMENT OF MOLECULAR AND IMMUNOHYSTOCHEMICAL MARKERS OF IMMUNE ENDOTHELIAL DAMAGE IN PREGNANTS WITH ARTERIAL HYPERTENSION AND PREECLAMSIA
Abstract
Prospective examination of 21 pregnant women with chronic arterial hypertension, 81 pregnant women with preeclamsia of various degree of severity and 25 healthy pregnant women was conducted. Comparative assessment of neurospecific proteins NSE and GFAP in blood serum and also immunomorphologic investigation of placenta tissue in women with hypertension and preeclampsia was demonstrated. Compared to blood serum and placenta tissue taken from women with preeclamsia, in women with arterial hypertension neurospecific proteins with high immunogenic activity that may lead to development of severe immunopathologic process were not discovered. Pregnancy prolongation with adequate hypotensive therapy and good blood pressure control is possible. Development of preeclampsia is associated with sudden increase in neurospecific protein levels, severe immune endothelial damage of macro-and microcirculation vessels; To stop the progression of this process is possible only with delivery, that is indicated in case of eclampsia, severe preeclampsia and in its moderate forms ineffective treatment.
About the Authors
I. S. Sidorova
GBOU VPO «First MSMU named after I.M. Sechenov» Ministry of Health and Social Development of Russia, Moscow
Russian Federation
Russian Federation
A. L. Unanayan
GBOU VPO «First MSMU named after I.M. Sechenov» Ministry of Health and Social Development of Russia, Moscow
Russian Federation
Russian Federation
N. A. Nikitina
GBOU VPO «First MSMU named after I.M. Sechenov» Ministry of Health and Social Development of Russia, Moscow
Russian Federation
Russian Federation
A. A. Rzaeva
GBOU VPO «First MSMU named after I.M. Sechenov» Ministry of Health and Social Development of Russia, Moscow
Russian Federation
Russian Federation
V. V. Kinyakin
GBOU VPO «First MSMU named after I.M. Sechenov» Ministry of Health and Social Development of Russia, Moscow
Russian Federation
Russian Federation
References
1. Анализ причин материнской смертности. Руководство для врачей. Под редакцией проф. А.П. Милованова. М. 2008; 228 с.
2. Габелова К.А., Арутюнян А.В., Зубжицкая Л.Б., Опарина Т.И., Парусов В.Н. Фиксированные иммунные комплексы и NO-синтетазная активность плаценты при гестозе. Вестник Российкой ассоциации акушеров-гинекологов. 2000; 1: 22-24.
3. Зубжицкая Л.Б., Кошелева Н.Г., Семенов В.В. Иммуноморфологическое состояние плаценты при акушерской патологии. Санкт-Петербург. 2005.
4. Чехонин В.П., Дмитриева Т.Б., Жирков Ю.А. Иммунохимический анализ нейроспецифических антигенов. М. 2000; 416 с.
5. Fabry I.G., Richart T., Chengz X., Van Bortel L.M., Staessen J.A. Diagnosis and treatment of hypertensive disorders during pregnancy. Acta Clin. Belg. 2010 Jul-Aug; 65 (4): 229-36.
6. Feinberg B.B. Preeclampsia: the death of Goliath. Am. J. Reprod. Immunol. 2006 Feb; 55 (2): 84-98.
7. Hutcheon J.A., Lisonkova S., Joseph K.S. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best. Pract. Res. Clin. Obstet. Gynaecol. 2011 Aug; 25 (4): 391-403.
8. Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. NICE Clinical Guidelines, No. 107. National Collaborating Centre for Women's and Children's Health (UK). London: RCOG Press; August 2010.
9. Jim B., Sharma S., Kebede T., Acharya A. Hypertension in pregnancy: a comprehensive update. Cardiol. Rev. 2010 Jul-Aug; 18 (4): 178-89.
10. Karthikeyan V.J., Lip G.Y. Endothelial damage/dysfunction and hypertension in pregnancy. Front. Biosci. (Elite Ed). 2011 Jun 1; 3: 1100-8.
11. Lazdam M., Davis E.F., Lewandowski A.J., Worton S.A. et al. Prevention of Vascular Dysfunction after Preeclampsia: A Potential Long-Term Outcome Measure and an Emerging Goal for Treatment. Journal of Pregnancy. 2012, Article ID 704146, 8 p.
12. Th le V., Schlitt A. Hypertensive diseases in pregnancy. Internist (Berl.). 2008 Jul; 49 (7): 811-6.
13. Uzan J., Carbonnel M., Piconne1 О., Asmar R., Ayoubi J.-M. Pre-eclampsia: pathophysiology, diagnosis and management. Vascular Health and Risk Management 2011; 7: 467-474.
14. Y cesoy G., Ozkan S., Bodur H., Tan T., Caliskan E., Vural B., Corakci A. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center. Arch Gynecol. Obstet. 2005 Nov.; 273 (1): 43-9.
15. Yulug E., Yenilmez E., Unsal M.A., Aydin S., Tekelioglu Y., Arvas H. Apoptotic and morphological features of the umbilical artery endothelium in mild and severe pre-eclampsia. Acta Obstetricia et Gynecologica. 2006; 85: 1038-1045.
Review
For citations:
Sidorova I.S., Unanayan A.L., Nikitina N.A., Rzaeva A.A., Kinyakin V.V. COMPARATIVE ASSESSMENT OF MOLECULAR AND IMMUNOHYSTOCHEMICAL MARKERS OF IMMUNE ENDOTHELIAL DAMAGE IN PREGNANTS WITH ARTERIAL HYPERTENSION AND PREECLAMSIA. Obstetrics, Gynecology and Reproduction. 2012;6(4):29-32. (In Russ.)
Views:
524
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
